
中东和非洲血液过滤器市场预测至 2028 年 - COVID-19 影响和按产品(40 微米和 70 微米、100 微米和 170 微米等)、材料(聚碳酸酯、聚酯、ABS 等)、应用进行区域分析(血液处理和输血)和最终用户(血库、医院等)
No. of Pages: 116 | Report Code: TIPRE00027049 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00027049 | Category: Life Sciences
血液过滤器通常在长期部署小时手术,例如肾移植,以及紧急情况。这些手术可能会导致失血过多,因此很难用新鲜血液来弥补失血,尤其是在稀有血型的情况下。由于需求充足,血液过滤器市场的主要参与者提供先进的全自动血液过滤器,以减少人为干预。 ExThera Medical Corp. 提供创新过滤器,其发明目的是从感染患者的血液中捕获和去除 SARS-CoV-2(COVID-19 的病原体)。其 Seraph Microbind 亲和血液过滤器或 Seraph 100 是一种外部一次性医疗过滤设备,旨在快速安全地从血液中去除任何病原体、毒素和其他致病污染物。美国食品和药物管理局 (FDA) 于 2020 年 4 月向不同设备授予了紧急使用授权 (EUA)。这些设备此前均未获得 FDA 批准用于此适应症,但它们正处于研发的后期阶段。因此,此类技术进步可能会在未来几年为中东和非洲血液过滤器市场带来新趋势。
COVID-19 大流行也对中东的社会经济状况产生了广泛影响。对于伊拉克、苏丹、南非和也门等该地区脆弱且饱受冲突蹂躏的国家来说,Covid-19大流行和经济衰退带来的挑战尤其令人恐惧,因为它们可能会导致进口低迷。全球贸易中断,进一步造成中东和非洲地区医疗用品和其他商品的短缺。这一因素也导致该地区的价格大幅上涨。自 Covid-19 爆发以来,大流行期间对血液过滤系统的需求呈趋势,目前医疗器械公司正在努力制定策略以帮助治疗 COVID-19。此外,采用血浆疗法治疗新冠肺炎患者也促进了血液过滤器市场的进步。据报道,阿联酋正在采用恢复期血浆(CP)疗法,从疾病康复者的血液中提取抗病毒抗体,并将其捐赠给危重病人。由于抗病毒药物仍在进行人体试验,CP 疗法在 2020 年在该地区变得非常重要。2020 年 4 月,阿布扎比谢赫哈利法医疗城的医务人员首次使用一名阿联酋人的血浆治疗了一名患者,该患者是从艾滋病中康复的。病毒。在阿联酋,Rashid 医院使用 CPT 治疗了 170 多名新冠患者,取得了良好的效果。 CPT 的使用导致对血液过滤器和其他用于分离血液成分的血液过滤装置的需求增加。
strong>
< h3>
Strategic insights for Middle East and Africa Blood Filter involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 29,338.38 thousand |
Market Size by 2028 | US$ 37,333.72 thousand |
Global CAGR (2021 - 2028) | 3.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa Blood Filter refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Blood Filter Market is valued at US$ 29,338.38 thousand in 2021, it is projected to reach US$ 37,333.72 thousand by 2028.
As per our report Middle East and Africa Blood Filter Market, the market size is valued at US$ 29,338.38 thousand in 2021, projecting it to reach US$ 37,333.72 thousand by 2028. This translates to a CAGR of approximately 3.5% during the forecast period.
The Middle East and Africa Blood Filter Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Blood Filter Market report:
The Middle East and Africa Blood Filter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Blood Filter Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Blood Filter Market value chain can benefit from the information contained in a comprehensive market report.